Acrux Limited (ACR) is an Australian drug delivery company dedicated to developing and commercialising topical pharmaceuticals products for global markets. ACR uses innovative technology to administer medicines through the skin. ACR conducts its operations in Australia, Switzerland, USA and overseas, with three marketed products including Testosterone Solution and Estradiol MDTS.
Acrux
Follow
Get notifications in MyBN when activity occurs.
Company Activity
NEW ROLE: Donald Brumley, Non-Executive Director | 03 Jul 2024 | |
NEWS: Tagged in Regeneus trebles on back of merger deal | 05 Apr 2024 | |
NEW ROLE: Mark Hyman, | 01 Mar 2022 | |
NEW ROLE: Nina Webster, Commercial Director | 24 Nov 2020 | |
NEW ROLE: Tim Bateman, Chief Financial Officer | 24 Nov 2020 | |
NEW ROLE: Felicia Colagrande, Product Development and Technical Affairs Director | 24 Nov 2020 | |
NEW ROLE: Charles O'Sullivan, Portfolio Directorá | 24 Nov 2020 | |
NEW ROLE: Norman Gray, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Deborah Ambrosini, Chief Financial Officer, Company Secretary | 03 Nov 2020 |